Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Randomized Trial of Efgartigimod Alfa for the Treatment of Incident Moderate to Severe Acute Optic Neuritis

NCT06453694 is registered in ClinicalTrials.gov with Anastasia Vishnevetsky, MD, MPH as lead sponsor.

NCT NCT06453694
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06453694 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Randomized Trial of Efgartigimod Alfa for the Treatment of Incident Moderate to Severe Acute Optic Neuritis
Lead sponsor
Anastasia Vishnevetsky, MD, MPH
Phase
Phase 2
Overall status
Recruiting
Start date
August 12, 2025
Completion date
July 31, 2027
Enrollment
20 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

optic neuritis